Page last updated: 2024-10-31

nefazodone and Gambling

nefazodone has been researched along with Gambling in 2 studies

nefazodone: may be useful as an opiate adjunct

Gambling: An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.

Research Excerpts

ExcerptRelevanceReference
"Fourteen outpatients who met DSM-IV criteria for pathological gambling were enrolled in a prospective 8-week open-label oral nefazodone trial."9.10Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. ( Baldini Rossi, N; Hollander, E; Pallanti, S; Sood, E, 2002)
"Fourteen outpatients who met DSM-IV criteria for pathological gambling were enrolled in a prospective 8-week open-label oral nefazodone trial."5.10Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. ( Baldini Rossi, N; Hollander, E; Pallanti, S; Sood, E, 2002)
"Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling."2.43Pharmacological treatments of pathological gambling. ( Baker, B; Baldini-Rossi, N; Hollander, E; Pallanti, S; Sood, E, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pallanti, S2
Baldini Rossi, N1
Sood, E2
Hollander, E2
Baldini-Rossi, N1
Baker, B1

Reviews

1 review available for nefazodone and Gambling

ArticleYear
Pharmacological treatments of pathological gambling.
    Journal of gambling studies, 2005,Spring, Volume: 21, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Comorbidity; Disruptive, I

2005

Trials

1 trial available for nefazodone and Gambling

ArticleYear
Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:11

    Topics: Adult; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Ad

2002